Astera Labs Statistics
Total Valuation
Astera Labs has a market cap or net worth of $32.49 billion. The enterprise value is $28.95 billion.
Important Dates
The next confirmed earnings date is Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Astera Labs has 171.25 million shares outstanding. The number of shares has increased by 36.79% in one year.
| Current Share Class | 171.25M |
| Shares Outstanding | 171.25M |
| Shares Change (YoY) | +36.79% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 11.01% |
| Owned by Institutions (%) | 68.06% |
| Float | 140.87M |
Valuation Ratios
The trailing PE ratio is 155.33 and the forward PE ratio is 76.18. Astera Labs's PEG ratio is 2.05.
| PE Ratio | 155.33 |
| Forward PE | 76.18 |
| PS Ratio | 35.31 |
| Forward PS | 21.88 |
| PB Ratio | 21.94 |
| P/TBV Ratio | 22.08 |
| P/FCF Ratio | 106.85 |
| P/OCF Ratio | 94.28 |
| PEG Ratio | 2.05 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 160.59, with an EV/FCF ratio of 102.74.
| EV / Earnings | 132.10 |
| EV / Sales | 33.95 |
| EV / EBITDA | 160.59 |
| EV / EBIT | 166.92 |
| EV / FCF | 102.74 |
Financial Position
The company has a current ratio of 10.24, with a Debt / Equity ratio of 0.02.
| Current Ratio | 10.24 |
| Quick Ratio | 9.56 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.11 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 18.82% and return on invested capital (ROIC) is 9.18%.
| Return on Equity (ROE) | 18.82% |
| Return on Assets (ROA) | 8.38% |
| Return on Invested Capital (ROIC) | 9.18% |
| Return on Capital Employed (ROCE) | 12.40% |
| Weighted Average Cost of Capital (WACC) | 14.09% |
| Revenue Per Employee | $1.13M |
| Profits Per Employee | $289,860 |
| Employee Count | 756 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 4.06 |
Taxes
| Income Tax | -981,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +223.11% in the last 52 weeks. The beta is 1.79, so Astera Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.79 |
| 52-Week Price Change | +223.11% |
| 50-Day Moving Average | 132.23 |
| 200-Day Moving Average | 158.68 |
| Relative Strength Index (RSI) | 78.71 |
| Average Volume (20 Days) | 4,931,552 |
Short Selling Information
The latest short interest is 15.50 million, so 9.05% of the outstanding shares have been sold short.
| Short Interest | 15.50M |
| Short Previous Month | 13.52M |
| Short % of Shares Out | 9.05% |
| Short % of Float | 11.00% |
| Short Ratio (days to cover) | 3.35 |
Income Statement
In the last 12 months, Astera Labs had revenue of $852.53 million and earned $219.13 million in profits. Earnings per share was $1.22.
| Revenue | 852.53M |
| Gross Profit | 645.26M |
| Operating Income | 173.42M |
| Pretax Income | 218.15M |
| Net Income | 219.13M |
| EBITDA | 180.25M |
| EBIT | 173.42M |
| Earnings Per Share (EPS) | $1.22 |
Full Income StatementBalance Sheet
The company has $1.19 billion in cash and $30.97 million in debt, with a net cash position of $1.16 billion or $6.76 per share.
| Cash & Cash Equivalents | 1.19B |
| Total Debt | 30.97M |
| Net Cash | 1.16B |
| Net Cash Per Share | $6.76 |
| Equity (Book Value) | 1.36B |
| Book Value Per Share | 8.01 |
| Working Capital | 1.23B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $319.31 million and capital expenditures -$37.54 million, giving a free cash flow of $281.76 million.
| Operating Cash Flow | 319.31M |
| Capital Expenditures | -37.54M |
| Depreciation & Amortization | 6.83M |
| Net Borrowing | n/a |
| Free Cash Flow | 281.76M |
| FCF Per Share | $1.65 |
Full Cash Flow StatementMargins
Gross margin is 75.69%, with operating and profit margins of 20.34% and 25.70%.
| Gross Margin | 75.69% |
| Operating Margin | 20.34% |
| Pretax Margin | 25.59% |
| Profit Margin | 25.70% |
| EBITDA Margin | 21.14% |
| EBIT Margin | 20.34% |
| FCF Margin | 33.05% |
Dividends & Yields
Astera Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.79% |
| Shareholder Yield | -36.79% |
| Earnings Yield | 0.73% |
| FCF Yield | 0.94% |
Analyst Forecast
The average price target for Astera Labs is $195.00, which is 2.78% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $195.00 |
| Price Target Difference | 2.78% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 20.94% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astera Labs has an Altman Z-Score of 76.61 and a Piotroski F-Score of 5.
| Altman Z-Score | 76.61 |
| Piotroski F-Score | 5 |
